July 12, 2019
Jack Goldstein, 14, and his family had to make sacrifices when Jack was diagnosed with leukemia. But when Jack put his schoolwork and baseball training on hold, his family and friends were there to support him.
May 10, 2019
After a two-year journey, Lorelei rings the bell at the UNC Pediatric Hematology Oncology clinic, signaling an end to her treatments for acute lymphoblastic leukemia.
January 10, 2019
Decorated military veteran MG Autry says service to others is central to his life. Even when he is facing his own health challenges, he would have it no other way.
December 21, 2018
UNC Lineberger’s Joshua Zeidner, MD, reported preliminary data at the 60th American Society of Hematology Annual Meeting from a phase II clinical trial for administering a high-dose of the chemotherapy treatment cytarabine followed by an immune checkpoint inhibitor, pembrolizumab, in patients with acute myeloid leukemia that had relapsed or no longer responded to other treatment.
December 20, 2018
November 8, 2018
A diagnosis with a rare type of blood cancer called acute promyelocytic leukemia just days before his wedding influenced Dustin Riedesel's perspective on marriage, and inspired him and his now-wife, Katie, to raise money to support cancer research.
October 29, 2018
Etteinne “ET” and W. G. Champion “Champ” Mitchell of New Bern, North Carolina, will create a new fund supporting ground-breaking research in blood cancer at UNC Lineberger Comprehensive Cancer Center, including lymphoma, leukemia and myeloma research, in gratitude for the care Champ received and to bolster research directed at finding cures.
August 29, 2018
In the journal Blood Advances, UNC Lineberger’s Ben Vincent, MD, Paul Armistead, MD, PhD, and their collaborators reported early findings from a new study that could aid in the development of immune-based treatments that are tailored to individual leukemia patients who are undergoing stem cell transplantation.
February 13, 2018
In the journal Nature, UNC Lineberger's Greg Wang, PhD, and colleagues reported findings about the structure and function of the DNMT3A enzyme complex, which helps control gene expression.
June 28, 2016
UNC Lineberger researchers led by Dr. William A. Wood found that for patients treated in a hospital, the risk of death from acute myeloid leukemia was elevated in three regions of the state compared to a benchmark.
